Ciprofloxacin Tablets USP — Class II drug recall D-220-2013
Terminated recall by West-ward Pharmaceutical Corp., reported 2013-04-03, distributed in AR, GA. Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxaci
| Recall number | D-220-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-ward Pharmaceutical Corp., Eatontown, NJ, United States |
| Recall initiated | 2013-02-06 |
| Classified | 2013-03-27 |
| Reported by FDA | 2013-04-03 |
| Terminated | 2014-08-04 |
| Distributed | AR, GA |
| Quantity | 7,136 units |
| NDC | 00143-9927, 00143-9927-01, 00143-9927-05, 00143-9927-30, 00143-9928, 00143-9928-01, 00143-9928-05, 00143-9928-30, 00143-9929, 00143-9929-01, 00143-9929-50 |
| Lot numbers | 06/16, CB222A |
Product
Ciprofloxacin Tablets USP, 500 mg, 100-count bottle, Rx only, Manufactured for West-ward Pharmaceutical Corp., Eatowntown, NJ 07724 by Hikma Pharmaceuticals, Amman, Jordan, NDC 0143-9928-01
Reason for recall
Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-220-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.